La chaîne d'options affiche les données clés des options sur actions de LAVA Therapeutics à différents prix d'exercice et dates d'expiration. Les traders utilisent ces informations pour analyser les transactions potentielles et évaluer le sentiment du marché pour LAVA Therapeutics..

LAVA Therapeutics (NASDAQ:LVTX) Stock, Chaîne d'Options

LAVA Therapeutics

LAVA Therapeutics NV isa clinical stage immuno-oncology company. It is focused on transforming cancer treatment by developing a platform to selectively induce bispecific antibody utilizing the Gammabody platform for an undisclosed tumor associated antigen for the treatment of cancer. Company's pipeline include's products such as LAVA-1266, LAVA-1427, LAVA-1433, LAVA-1207, PF08046052, JNJ89853413.

LAVA Therapeutics NV

News

Press Releases

XOMA Royalty Enters into Agreement to Acquire LAVA Therapeutics for Between $1.16 and $1.24 Per Share in Cash, Plus a Contingent Value Right

LVTX Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of Lava Therapeutics N.V. Is Fair to Shareholders

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates SCS, HNI, LVTX, HLVX on Behalf of Shareholders

SHAREHOLDER ALERT: The M&A Class Action Firm Announces An Investigation of LAVA Therapeutics N.V. (NASDAQ: LVTX)

Small Cap

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates SCS, LVTX, ENZB on Behalf of Shareholders

Earnings

LAVA Reports Second Quarter 2025 Financial Results and Provides Corporate Update

LAVA Therapeutics to Move Extraordinary General Meeting to Early November 2025

XOMA Royalty Extends Tender Offer to Acquire LAVA Therapeutics N.V.

XOMA Royalty and LAVA Therapeutics Announce Amendment to Purchase Agreement

Shareholder Alert: The Ademi Firm investigates whether LAVA Therapeutics N.V. is obtaining a Fair Price for its Public Shareholders in the Amendment to the Purchase Agreement

ENZB

HLVX

LVTX

XOMA

XOMAO

XOMAP

Actinium Pharmaceuticals, Inc. (Delaware) Common Stock

Actinium Pharma

BioAtla

BioXcel Therapeutics, Inc. - Common Stock

BioXcel Therapeutics

Celularity

CEL-SCI

Dyadic International, Inc. - Common Stock

Dyadic International

Elutia

Evaxion

FibroGen

Generation Bio

INmune Bio

Kezar Life Sciences

Liminatus Pharma, Inc. - Class A Common Stock

Liminatus Pharma

Lantern Pharma

MAIA Biotechnology

Mersana Therapeutics, Inc. - Common Stock

Mersana Therapeutics

Mural Oncology

OnKure Therapeutics, Inc. - Class A Common Stock

OnKure Therapeutics

PDS Biotechnology Corporation - Common Stock

PDS Biotechnology

Radiopharm Theranostics Limited - American Depositary Shares

Radiopharm Theranostics

Rein Therapeutics

RenovoRx

Skye Bioscience

Xilio Therapeutics

XOMA Royalty Corporation - Depositary Shares Rep Series B 8.375% Cumulative Preferred Stock

Comments

LAVA Therapeutics

LAVA Therapeutics (LVTX) Options

LAVA Therapeutics (NASDAQ:LVTX) Stock, Chaîne d'Options

Notizie

PARTENAIRE / CONTRIBUTEUR

BENZINGA MONDIAL